PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: CSO Precision Medicine Presentation, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 782 Posts.
    lightbulb Created with Sketch. 66
    Hi Maxter,
    Thanks for that chart.I am not sure that your charts allow for fun and games being played out by brokers.I have noticed that someone has been trying to keep the lid on their buying by putting up dummy sales bids and then moving them further higher in case they get taken out.There was a lot to sell at 11.5c and as the market opened they put the bid up to 12.5c
    Once buyers know this fact they become more aggressive as the mountain on sales sides are just phoney sellers.Anyway trading will make that clearer.

    The AML trial due to finish in the middle of the year...has orphan drug status...if successful has a quicker way to commercialisation which will really excite the market and the speculation will start early as there is big money involved on success.

    http://pharmaceuticalcommerce.com/opinion/common-misconceptions-about-the-orphan-drug-designation/
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.